Dr. Lbr Medi Care & Research Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 3.40 M
as on 06-07-2024
- Paid Up Capital ₹ 1.80 M
as on 06-07-2024
- Company Age 3 years 6 months
- Last Filing with ROC 31 Mar 2023
About Dr. Lbr Medi Care & Research
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.40 M and a paid-up capital of Rs 1.80 M, as per the Ministry of Corporate Affairs (MCA) records.
Roshan Jindal, Surender Garg, Ritu Jindal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85190CH2021PTC043574
- Company No.
043574
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Mar 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Dr. Lbr Medi Care & Research Private Limited offer?
Dr. Lbr Medi Care & Research Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Capsules, Anti Infective Drugs & Medicines, Antibacterial Drugs, Hand Sanitizers & Personal Hygiene, Beauty Soap, Pain Relief Drugs & Pharmaceuticals, Osteoporosis Medications, Anti Inflammatory Drugs, Nutraceuticals & Dietary Supplements.
Who are the key members and board of directors at Dr. Lbr Medi Care & Research?
Board Members(5)
Financial Performance and Corporate Structure Insights of Dr. Lbr Medi Care & Research.
Enhance accessibility to Dr. Lbr Medi Care & Research's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| FY 2022 | FY 2021 | FY 2020 | FY 2019 | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dr. Lbr Medi Care & Research?
Unlock access to Dr. Lbr Medi Care & Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
7 years 11 months Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr. Lbr Medi Care & Research?
Dr. Lbr Medi Care & Research has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Lbr Medi Care & Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Lbr Medi Care & Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
